
### [MONDO:0005627](http://purl.obolibrary.org/obo/MONDO_0005627)
**Label:** head and neck malignant neoplasia

**Subclasses:** [MONDO:0019317](http://purl.obolibrary.org/obo/MONDO_0019317) (follicular atrophoderma-basal cell carcinoma), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0004615](http://purl.obolibrary.org/obo/MONDO_0004615) (upper gum cancer), [MONDO:0002434](http://purl.obolibrary.org/obo/MONDO_0002434) (malignant oculomotor nerve tumor), [MONDO:0004611](http://purl.obolibrary.org/obo/MONDO_0004611) (soft palate cancer), [MONDO:0002433](http://purl.obolibrary.org/obo/MONDO_0002433) (cranial nerve malignant neoplasm), [MONDO:0006358](http://purl.obolibrary.org/obo/MONDO_0006358) (parotid gland squamous cell carcinoma), [MONDO:0002432](http://purl.obolibrary.org/obo/MONDO_0002432) (malignant neoplasm of acoustic nerve), [MONDO:0006357](http://purl.obolibrary.org/obo/MONDO_0006357) (parotid gland carcinoma ex pleomorphic adenoma), [MONDO:0001580](http://purl.obolibrary.org/obo/MONDO_0001580) (lacrimal duct cancer), [MONDO:0006356](http://purl.obolibrary.org/obo/MONDO_0006356) (parotid gland adenoid cystic carcinoma), [MONDO:0003880](http://purl.obolibrary.org/obo/MONDO_0003880) (ceruminous carcinoma), [MONDO:0006355](http://purl.obolibrary.org/obo/MONDO_0006355) (parotid gland acinic cell carcinoma), [MONDO:0000371](http://purl.obolibrary.org/obo/MONDO_0000371) (oral cavity carcinoma in situ), [MONDO:0006352](http://purl.obolibrary.org/obo/MONDO_0006352) (paranasal sinus adenoid cystic carcinoma), [MONDO:0004292](http://purl.obolibrary.org/obo/MONDO_0004292) (supraglottis verrucous carcinoma), [MONDO:0004293](http://purl.obolibrary.org/obo/MONDO_0004293) (supraglottis squamous cell carcinoma), [MONDO:0004290](http://purl.obolibrary.org/obo/MONDO_0004290) (subglottis verrucous carcinoma), [MONDO:0004291](http://purl.obolibrary.org/obo/MONDO_0004291) (subglottis squamous cell carcinoma), [MONDO:0021070](http://purl.obolibrary.org/obo/MONDO_0021070) (sublingual gland carcinoma), [MONDO:0005837](http://purl.obolibrary.org/obo/MONDO_0005837) (mandibular cancer), [MONDO:0004624](http://purl.obolibrary.org/obo/MONDO_0004624) (uvula cancer), [MONDO:0004621](http://purl.obolibrary.org/obo/MONDO_0004621) (upper lip cancer), [MONDO:0000380](http://purl.obolibrary.org/obo/MONDO_0000380) (paranasal sinus cancer), [MONDO:0004188](http://purl.obolibrary.org/obo/MONDO_0004188) (iris spindle cell melanoma), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0004065](http://purl.obolibrary.org/obo/MONDO_0004065) (intermediate cell type choroid melanoma), [MONDO:0004066](http://purl.obolibrary.org/obo/MONDO_0004066) (intermediate cell type ciliary body melanoma), [MONDO:0004063](http://purl.obolibrary.org/obo/MONDO_0004063) (intermediate cell type iris melanoma), [MONDO:0004064](http://purl.obolibrary.org/obo/MONDO_0004064) (iris melanoma), [MONDO:0004062](http://purl.obolibrary.org/obo/MONDO_0004062) (intermediate cell type uveal melanoma), [MONDO:0003092](http://purl.obolibrary.org/obo/MONDO_0003092) (lacrimal gland mucoepidermoid carcinoma), [MONDO:0004719](http://purl.obolibrary.org/obo/MONDO_0004719) (hard palate cancer), [MONDO:0002659](http://purl.obolibrary.org/obo/MONDO_0002659) (uveal cancer), [MONDO:0002658](http://purl.obolibrary.org/obo/MONDO_0002658) (iris cancer), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0004958](http://purl.obolibrary.org/obo/MONDO_0004958) (oral squamous cell carcinoma), [MONDO:0002418](http://purl.obolibrary.org/obo/MONDO_0002418) (ethmoid sinus adenocarcinoma), [MONDO:0003745](http://purl.obolibrary.org/obo/MONDO_0003745) (choroid spindle cell melanoma), [MONDO:0004713](http://purl.obolibrary.org/obo/MONDO_0004713) (lower gum cancer), [MONDO:0003746](http://purl.obolibrary.org/obo/MONDO_0003746) (ciliary body spindle cell melanoma), [MONDO:0003501](http://purl.obolibrary.org/obo/MONDO_0003501) (external ear squamous cell carcinoma), [MONDO:0003744](http://purl.obolibrary.org/obo/MONDO_0003744) (spindle cell intraocular melanoma), [MONDO:0003189](http://purl.obolibrary.org/obo/MONDO_0003189) (middle ear adenocarcinoma), [MONDO:0002892](http://purl.obolibrary.org/obo/MONDO_0002892) (skull base chordoma), [MONDO:0002894](http://purl.obolibrary.org/obo/MONDO_0002894) (spinal chordoma), [MONDO:0004034](http://purl.obolibrary.org/obo/MONDO_0004034) (eye lymphoma), [MONDO:0006213](http://purl.obolibrary.org/obo/MONDO_0006213) (floor of mouth mucoepidermoid carcinoma), [MONDO:0002096](http://purl.obolibrary.org/obo/MONDO_0002096) (malignant conjunctival melanoma), [MONDO:0021297](http://purl.obolibrary.org/obo/MONDO_0021297) (carcinoma in situ of nasopharynx), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0000928](http://purl.obolibrary.org/obo/MONDO_0000928) (eyelid melanoma), [MONDO:0010150](http://purl.obolibrary.org/obo/MONDO_0010150) (head and neck squamous cell carcinoma), [MONDO:0004607](http://purl.obolibrary.org/obo/MONDO_0004607) (vallecula cancer), [MONDO:0004727](http://purl.obolibrary.org/obo/MONDO_0004727) (vestibule of mouth cancer), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary adenocarcinoma (disease)), [MONDO:0004724](http://purl.obolibrary.org/obo/MONDO_0004724) (submandibular gland cancer), [MONDO:0003878](http://purl.obolibrary.org/obo/MONDO_0003878) (malignant choroid melanoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0021280](http://purl.obolibrary.org/obo/MONDO_0021280) (mucoepidermoid carcinoma of parotid gland), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0004289](http://purl.obolibrary.org/obo/MONDO_0004289) (glottis verrucous carcinoma), [MONDO:0004045](http://purl.obolibrary.org/obo/MONDO_0004045) (pediatric intraocular retinoblastoma), [MONDO:0003076](http://purl.obolibrary.org/obo/MONDO_0003076) (unilateral retinoblastoma), [MONDO:0003075](http://purl.obolibrary.org/obo/MONDO_0003075) (bilateral retinoblastoma), [MONDO:0003078](http://purl.obolibrary.org/obo/MONDO_0003078) (extraocular retinoblastoma), [MONDO:0003077](http://purl.obolibrary.org/obo/MONDO_0003077) (intraocular retinoblastoma), [MONDO:0003072](http://purl.obolibrary.org/obo/MONDO_0003072) (retinal cancer), [MONDO:0003074](http://purl.obolibrary.org/obo/MONDO_0003074) (familial retinoblastoma), [MONDO:0003073](http://purl.obolibrary.org/obo/MONDO_0003073) (trilateral retinoblastoma), [MONDO:0003190](http://purl.obolibrary.org/obo/MONDO_0003190) (middle ear carcinoma), [MONDO:0021431](http://purl.obolibrary.org/obo/MONDO_0021431) (squamous cell carcinoma of buccal mucosa), [MONDO:0021310](http://purl.obolibrary.org/obo/MONDO_0021310) (malignant tumor of neck), [MONDO:0021313](http://purl.obolibrary.org/obo/MONDO_0021313) (eyelid cancer), [MONDO:0005507](http://purl.obolibrary.org/obo/MONDO_0005507) (gingival cancer), [MONDO:0002236](http://purl.obolibrary.org/obo/MONDO_0002236) (ocular cancer), [MONDO:0004659](http://purl.obolibrary.org/obo/MONDO_0004659) (eye carcinoma in situ), [MONDO:0006834](http://purl.obolibrary.org/obo/MONDO_0006834) (lip cancer), [MONDO:0021316](http://purl.obolibrary.org/obo/MONDO_0021316) (malignant tumor of minor salivary gland), [MONDO:0002475](http://purl.obolibrary.org/obo/MONDO_0002475) (lacrimal gland adenocarcinoma), [MONDO:0003202](http://purl.obolibrary.org/obo/MONDO_0003202) (pituitary gland basophilic carcinoma), [MONDO:0004650](http://purl.obolibrary.org/obo/MONDO_0004650) (malignant carotid body paraganglioma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0021429](http://purl.obolibrary.org/obo/MONDO_0021429) (squamous cell carcinoma of floor of mouth), [MONDO:0004669](http://purl.obolibrary.org/obo/MONDO_0004669) (salivary gland cancer), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0004667](http://purl.obolibrary.org/obo/MONDO_0004667) (sublingual gland cancer), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0005515](http://purl.obolibrary.org/obo/MONDO_0005515) (oral cavity cancer), [MONDO:0003212](http://purl.obolibrary.org/obo/MONDO_0003212) (nasal cavity carcinoma), [MONDO:0003211](http://purl.obolibrary.org/obo/MONDO_0003211) (nasal cavity adenocarcinoma), [MONDO:0003574](http://purl.obolibrary.org/obo/MONDO_0003574) (external ear cancer), [MONDO:0003454](http://purl.obolibrary.org/obo/MONDO_0003454) (conjunctival cancer), [MONDO:0006286](http://purl.obolibrary.org/obo/MONDO_0006286) (major salivary gland mucoepidermoid carcinoma), [MONDO:0006285](http://purl.obolibrary.org/obo/MONDO_0006285) (major salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006284](http://purl.obolibrary.org/obo/MONDO_0006284) (major salivary gland carcinoma), [MONDO:0010535](http://purl.obolibrary.org/obo/MONDO_0010535) (Bazex-DuprC)-Christol syndrome), [MONDO:0021538](http://purl.obolibrary.org/obo/MONDO_0021538) (verrucous carcinoma of oral cavity), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0001129](http://purl.obolibrary.org/obo/MONDO_0001129) (nasal cavity olfactory neuroblastoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0004636](http://purl.obolibrary.org/obo/MONDO_0004636) (lip carcinoma in situ), [MONDO:0001128](http://purl.obolibrary.org/obo/MONDO_0001128) (nasal cavity cancer), [MONDO:0021537](http://purl.obolibrary.org/obo/MONDO_0021537) (undifferentiated carcinoma of nasopharynx), [MONDO:0002579](http://purl.obolibrary.org/obo/MONDO_0002579) (orbit embryonal rhabdomyosarcoma), [MONDO:0004631](http://purl.obolibrary.org/obo/MONDO_0004631) (tongue cancer), [MONDO:0003784](http://purl.obolibrary.org/obo/MONDO_0003784) (nasal cavity carcinoma in situ), [MONDO:0004510](http://purl.obolibrary.org/obo/MONDO_0004510) (inflammatory liposarcoma), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0006372](http://purl.obolibrary.org/obo/MONDO_0006372) (pituicytoma), [MONDO:0002109](http://purl.obolibrary.org/obo/MONDO_0002109) (pituitary cancer), [MONDO:0004645](http://purl.obolibrary.org/obo/MONDO_0004645) (cheek mucosa cancer), [MONDO:0002469](http://purl.obolibrary.org/obo/MONDO_0002469) (lacrimal gland carcinoma ex pleomorphic adenoma), [MONDO:0002464](http://purl.obolibrary.org/obo/MONDO_0002464) (lacrimal gland cancer), [MONDO:0002463](http://purl.obolibrary.org/obo/MONDO_0002463) (lacrimal gland carcinoma), [MONDO:0006700](http://purl.obolibrary.org/obo/MONDO_0006700) (choroid cancer), [MONDO:0002466](http://purl.obolibrary.org/obo/MONDO_0002466) (eye carcinoma), [MONDO:0002460](http://purl.obolibrary.org/obo/MONDO_0002460) (lacrimal system cancer), [MONDO:0002580](http://purl.obolibrary.org/obo/MONDO_0002580) (orbit rhabdomyosarcoma), [MONDO:0006388](http://purl.obolibrary.org/obo/MONDO_0006388) (prolactin-producing pituitary gland carcinoma), [MONDO:0006145](http://purl.obolibrary.org/obo/MONDO_0006145) (chondroid chordoma), [MONDO:0001130](http://purl.obolibrary.org/obo/MONDO_0001130) (nasal cavity lymphoma), [MONDO:0006265](http://purl.obolibrary.org/obo/MONDO_0006265) (laryngeal small cell carcinoma), [MONDO:0004085](http://purl.obolibrary.org/obo/MONDO_0004085) (choroid epithelioid cell melanoma), [MONDO:0006385](http://purl.obolibrary.org/obo/MONDO_0006385) (primary intraosseous squamous cell carcinoma), [MONDO:0004086](http://purl.obolibrary.org/obo/MONDO_0004086) (ciliary body epithelioid cell melanoma), [MONDO:0006262](http://purl.obolibrary.org/obo/MONDO_0006262) (lacrimal gland adenoid cystic carcinoma), [MONDO:0004080](http://purl.obolibrary.org/obo/MONDO_0004080) (glottis squamous cell carcinoma), [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0003927](http://purl.obolibrary.org/obo/MONDO_0003927) (posterior uveal melanoma), [MONDO:0001748](http://purl.obolibrary.org/obo/MONDO_0001748) (maxillary sinus cancer), [MONDO:0003802](http://purl.obolibrary.org/obo/MONDO_0003802) (cornea cancer), [MONDO:0002831](http://purl.obolibrary.org/obo/MONDO_0002831) (non-keratinizing sinonasal squamous cell carcinoma), [MONDO:0002038](http://purl.obolibrary.org/obo/MONDO_0002038) (head and neck carcinoma), [MONDO:0004216](http://purl.obolibrary.org/obo/MONDO_0004216) (pineal region germinoma), [MONDO:0001743](http://purl.obolibrary.org/obo/MONDO_0001743) (paranasal sinus lymphoma), [MONDO:0004338](http://purl.obolibrary.org/obo/MONDO_0004338) (retinal cell cancer), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (susceptibility to uveal melanoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0003487](http://purl.obolibrary.org/obo/MONDO_0003487) (adenoid squamous cell carcinoma), [MONDO:0006079](http://purl.obolibrary.org/obo/MONDO_0006079) (ameloblastic carcinoma), [MONDO:0006073](http://purl.obolibrary.org/obo/MONDO_0006073) (adenomatoid odontogenic tumor), [MONDO:0021343](http://purl.obolibrary.org/obo/MONDO_0021343) (carcinoma of floor of mouth), [MONDO:0001756](http://purl.obolibrary.org/obo/MONDO_0001756) (frontal sinus cancer), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0002969](http://purl.obolibrary.org/obo/MONDO_0002969) (ciliary body cancer), [MONDO:0001758](http://purl.obolibrary.org/obo/MONDO_0001758) (paranasal sinus sarcoma), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0003932](http://purl.obolibrary.org/obo/MONDO_0003932) (childhood optic nerve glioma), [MONDO:0001994](http://purl.obolibrary.org/obo/MONDO_0001994) (sphenoidal sinus cancer), [MONDO:0006405](http://purl.obolibrary.org/obo/MONDO_0006405) (salivary gland small cell carcinoma), [MONDO:0004349](http://purl.obolibrary.org/obo/MONDO_0004349) (retina lymphoma), [MONDO:0003931](http://purl.obolibrary.org/obo/MONDO_0003931) (childhood optic tract astrocytoma), [MONDO:0000545](http://purl.obolibrary.org/obo/MONDO_0000545) (sublingual gland adenoid cystic carcinoma), [MONDO:0006404](http://purl.obolibrary.org/obo/MONDO_0006404) (salivary gland large cell carcinoma), [MONDO:0006403](http://purl.obolibrary.org/obo/MONDO_0006403) (salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006402](http://purl.obolibrary.org/obo/MONDO_0006402) (salivary gland basal cell adenocarcinoma), [MONDO:0006401](http://purl.obolibrary.org/obo/MONDO_0006401) (salivary gland adenosquamous carcinoma), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0000518](http://purl.obolibrary.org/obo/MONDO_0000518) (sacrum chordoma), [MONDO:0021333](http://purl.obolibrary.org/obo/MONDO_0021333) (carcinoma of lip), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003589](http://purl.obolibrary.org/obo/MONDO_0003589) (liposarcoma of the ovary), [MONDO:0021339](http://purl.obolibrary.org/obo/MONDO_0021339) (carcinoma of hard palate), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0003587](http://purl.obolibrary.org/obo/MONDO_0003587) (pediatric liposarcoma), [MONDO:0003588](http://purl.obolibrary.org/obo/MONDO_0003588) (larynx liposarcoma), [MONDO:0004556](http://purl.obolibrary.org/obo/MONDO_0004556) (carcinoma arising in nasal papillomatosis), [MONDO:0003585](http://purl.obolibrary.org/obo/MONDO_0003585) (adult liposarcoma), [MONDO:0003586](http://purl.obolibrary.org/obo/MONDO_0003586) (esophagus liposarcoma), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0004673](http://purl.obolibrary.org/obo/MONDO_0004673) (lower lip cancer), [MONDO:0021331](http://purl.obolibrary.org/obo/MONDO_0021331) (carcinoma of parotid gland), [MONDO:0002132](http://purl.obolibrary.org/obo/MONDO_0002132) (skull cancer), [MONDO:0002131](http://purl.obolibrary.org/obo/MONDO_0002131) (jaw cancer), [MONDO:0004550](http://purl.obolibrary.org/obo/MONDO_0004550) (malignant cornea melanoma), [MONDO:0006297](http://purl.obolibrary.org/obo/MONDO_0006297) (maxillary sinus adenoid cystic carcinoma), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma, susceptibility to, 1), [MONDO:0006173](http://purl.obolibrary.org/obo/MONDO_0006173) (conjunctival squamous cell carcinoma), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharyngeal carcinoma), [MONDO:0006291](http://purl.obolibrary.org/obo/MONDO_0006291) (malignant jugulotympanic paraganglioma), [MONDO:0021329](http://purl.obolibrary.org/obo/MONDO_0021329) (carcinoma of soft palate), [MONDO:0002944](http://purl.obolibrary.org/obo/MONDO_0002944) (external ear carcinoma), [MONDO:0003912](http://purl.obolibrary.org/obo/MONDO_0003912) (malignant ciliary body melanoma), [MONDO:0003913](http://purl.obolibrary.org/obo/MONDO_0003913) (choroid mixed cell melanoma), [MONDO:0004328](http://purl.obolibrary.org/obo/MONDO_0004328) (maxillary sinus adenocarcinoma), [MONDO:0003910](http://purl.obolibrary.org/obo/MONDO_0003910) (mixed cell uveal melanoma), [MONDO:0000521](http://purl.obolibrary.org/obo/MONDO_0000521) (salivary gland carcinoma), [MONDO:0003911](http://purl.obolibrary.org/obo/MONDO_0003911) (ciliary body mixed cell melanoma), [MONDO:0004447](http://purl.obolibrary.org/obo/MONDO_0004447) (pituitary stalk meningioma), [MONDO:0002943](http://purl.obolibrary.org/obo/MONDO_0002943) (external ear basal cell carcinoma), [MONDO:0003234](http://purl.obolibrary.org/obo/MONDO_0003234) (optic nerve astrocytoma), [MONDO:0004446](http://purl.obolibrary.org/obo/MONDO_0004446) (olfactory groove meningioma), [MONDO:0003599](http://purl.obolibrary.org/obo/MONDO_0003599) (vulvar liposarcoma), [MONDO:0003596](http://purl.obolibrary.org/obo/MONDO_0003596) (spindle cell liposarcoma), [MONDO:0003235](http://purl.obolibrary.org/obo/MONDO_0003235) (optic nerve glioma), [MONDO:0003597](http://purl.obolibrary.org/obo/MONDO_0003597) (mixed-type liposarcoma), [MONDO:0003594](http://purl.obolibrary.org/obo/MONDO_0003594) (mixed liposarcoma), [MONDO:0003592](http://purl.obolibrary.org/obo/MONDO_0003592) (gastric liposarcoma), [MONDO:0021320](http://purl.obolibrary.org/obo/MONDO_0021320) (malignant tumor of floor of mouth), [MONDO:0003593](http://purl.obolibrary.org/obo/MONDO_0003593) (breast liposarcoma), [MONDO:0004561](http://purl.obolibrary.org/obo/MONDO_0004561) (retinal melanoma), [MONDO:0004682](http://purl.obolibrary.org/obo/MONDO_0004682) (retromolar area cancer), [MONDO:0003590](http://purl.obolibrary.org/obo/MONDO_0003590) (fibroblastic liposarcoma), [MONDO:0003591](http://purl.obolibrary.org/obo/MONDO_0003591) (kidney liposarcoma), [MONDO:0006060](http://purl.obolibrary.org/obo/MONDO_0006060) (nasopharyngeal squamous cell carcinoma), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0003849](http://purl.obolibrary.org/obo/MONDO_0003849) (clivus chordoma), [MONDO:0021279](http://purl.obolibrary.org/obo/MONDO_0021279) (mucoepidermoid carcinoma of submandibular gland), [MONDO:0003602](http://purl.obolibrary.org/obo/MONDO_0003602) (intracranial liposarcoma), [MONDO:0003600](http://purl.obolibrary.org/obo/MONDO_0003600) (cutaneous liposarcoma), [MONDO:0002634](http://purl.obolibrary.org/obo/MONDO_0002634) (liposarcoma of bone), [MONDO:0003601](http://purl.obolibrary.org/obo/MONDO_0003601) (mediastinum liposarcoma), [MONDO:0006436](http://purl.obolibrary.org/obo/MONDO_0006436) (submandibular gland adenoid cystic carcinoma), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0006435](http://purl.obolibrary.org/obo/MONDO_0006435) (submandibular gland adenocarcinoma), [MONDO:0017206](http://purl.obolibrary.org/obo/MONDO_0017206) (primary intraocular lymphoma), [MONDO:0017205](http://purl.obolibrary.org/obo/MONDO_0017205) (primary oculocerebral lymphoma), [MONDO:0002889](http://purl.obolibrary.org/obo/MONDO_0002889) (orbital cancer), [MONDO:0004700](http://purl.obolibrary.org/obo/MONDO_0004700) (parotid gland cancer), [MONDO:0006329](http://purl.obolibrary.org/obo/MONDO_0006329) (olfactory neuroblastoma), [MONDO:0004942](http://purl.obolibrary.org/obo/MONDO_0004942) (orbit lymphoma), [MONDO:0002888](http://purl.obolibrary.org/obo/MONDO_0002888) (intraorbital meningioma), [MONDO:0002766](http://purl.obolibrary.org/obo/MONDO_0002766) (larynx verrucous carcinoma), [MONDO:0004943](http://purl.obolibrary.org/obo/MONDO_0004943) (orbit sarcoma), [MONDO:0008978](http://purl.obolibrary.org/obo/MONDO_0008978) (chordoma (disease)), [MONDO:0006327](http://purl.obolibrary.org/obo/MONDO_0006327) (ocular sebaceous carcinoma), [MONDO:0005238](http://purl.obolibrary.org/obo/MONDO_0005238) (round cell liposarcoma), [MONDO:0006326](http://purl.obolibrary.org/obo/MONDO_0006326) (ocular melanoma with extraocular extension), [MONDO:0006325](http://purl.obolibrary.org/obo/MONDO_0006325) (ocular melanoma), [MONDO:0003850](http://purl.obolibrary.org/obo/MONDO_0003850) (clivus chondroid chordoma), [MONDO:0003175](http://purl.obolibrary.org/obo/MONDO_0003175) (salivary gland adenoid cystic carcinoma), [MONDO:0006201](http://purl.obolibrary.org/obo/MONDO_0006201) (ethmoid sinus adenoid cystic carcinoma), [MONDO:0020175](http://purl.obolibrary.org/obo/MONDO_0020175) (malignant tumor of palpebral epidermis), [MONDO:0006200](http://purl.obolibrary.org/obo/MONDO_0006200) (epithelioid cell uveal melanoma), [MONDO:0005595](http://purl.obolibrary.org/obo/MONDO_0005595) (laryngeal squamous cell carcinoma), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0002978](http://purl.obolibrary.org/obo/MONDO_0002978) (orbit alveolar rhabdomyosarcoma), [MONDO:0001763](http://purl.obolibrary.org/obo/MONDO_0001763) (ethmoid sinus cancer), [MONDO:0003389](http://purl.obolibrary.org/obo/MONDO_0003389) (epithelial-myoepithelial carcinoma), [MONDO:0004351](http://purl.obolibrary.org/obo/MONDO_0004351) (intraocular lymphoma), [MONDO:0007187](http://purl.obolibrary.org/obo/MONDO_0007187) (nevoid basal cell carcinoma syndrome), [MONDO:0004350](http://purl.obolibrary.org/obo/MONDO_0004350) (pediatric extraocular retinoblastoma), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0021009](http://purl.obolibrary.org/obo/MONDO_0021009) (salivary gland mucoepidermoid carcinoma), [MONDO:0003278](http://purl.obolibrary.org/obo/MONDO_0003278) (inner ear cancer), [MONDO:0003277](http://purl.obolibrary.org/obo/MONDO_0003277) (malignant ear neoplasm), [MONDO:0006303](http://purl.obolibrary.org/obo/MONDO_0006303) (middle ear squamous cell carcinoma), [MONDO:0004364](http://purl.obolibrary.org/obo/MONDO_0004364) (choroid necrotic melanoma), [MONDO:0004365](http://purl.obolibrary.org/obo/MONDO_0004365) (necrotic uveal melanoma), [MONDO:0003275](http://purl.obolibrary.org/obo/MONDO_0003275) (middle ear cancer), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0046855](http://purl.obolibrary.org/obo/GO_0046855) (inositol phosphate dephosphorylation), [GO:0046856](http://purl.obolibrary.org/obo/GO_0046856) (phosphatidylinositol dephosphorylation), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0046621](http://purl.obolibrary.org/obo/GO_0046621) (negative regulation of organ growth), [GO:2000808](http://purl.obolibrary.org/obo/GO_2000808) (negative regulation of synaptic vesicle clustering), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0021542](http://purl.obolibrary.org/obo/GO_0021542) (dentate gyrus development), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0051895](http://purl.obolibrary.org/obo/GO_0051895) (negative regulation of focal adhesion assembly), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0051896](http://purl.obolibrary.org/obo/GO_0051896) (regulation of protein kinase B signaling), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0006606](http://purl.obolibrary.org/obo/GO_0006606) (protein import into nucleus), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0060024](http://purl.obolibrary.org/obo/GO_0060024) (rhythmic synaptic transmission), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0045792](http://purl.obolibrary.org/obo/GO_0045792) (negative regulation of cell size), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0010997](http://purl.obolibrary.org/obo/GO_0010997) (anaphase-promoting complex binding), [GO:0051548](http://purl.obolibrary.org/obo/GO_0051548) (negative regulation of keratinocyte migration), [GO:0060134](http://purl.obolibrary.org/obo/GO_0060134) (prepulse inhibition), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:0036462](http://purl.obolibrary.org/obo/GO_0036462) (TRAIL-activated apoptotic signaling pathway), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:1901017](http://purl.obolibrary.org/obo/GO_1901017) (negative regulation of potassium ion transmembrane transporter activity), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:1990314](http://purl.obolibrary.org/obo/GO_1990314) (cellular response to insulin-like growth factor stimulus), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0002902](http://purl.obolibrary.org/obo/GO_0002902) (regulation of B cell apoptotic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0032535](http://purl.obolibrary.org/obo/GO_0032535) (regulation of cellular component size), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0030476](http://purl.obolibrary.org/obo/GO_0030476) (ascospore wall assembly), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0036294](http://purl.obolibrary.org/obo/GO_0036294) (cellular response to decreased oxygen levels), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0048681](http://purl.obolibrary.org/obo/GO_0048681) (negative regulation of axon regeneration), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0033698](http://purl.obolibrary.org/obo/GO_0033698) (Rpd3L complex), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0061408](http://purl.obolibrary.org/obo/GO_0061408) (positive regulation of transcription from RNA polymerase II promoter in response to heat stress), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0035749](http://purl.obolibrary.org/obo/GO_0035749) (myelin sheath adaxonal region), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0060341](http://purl.obolibrary.org/obo/GO_0060341) (regulation of cellular localization), [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission), [GO:2000060](http://purl.obolibrary.org/obo/GO_2000060) (positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0035064](http://purl.obolibrary.org/obo/GO_0035064) (methylated histone binding), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:1903984](http://purl.obolibrary.org/obo/GO_1903984) (positive regulation of TRAIL-activated apoptotic signaling pathway), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0090071](http://purl.obolibrary.org/obo/GO_0090071) (negative regulation of ribosome biogenesis), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004438](http://purl.obolibrary.org/obo/GO_0004438) (phosphatidylinositol-3-phosphatase activity), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0031939](http://purl.obolibrary.org/obo/GO_0031939) (negative regulation of chromatin silencing at telomere), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0016314](http://purl.obolibrary.org/obo/GO_0016314) (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0002275](http://purl.obolibrary.org/obo/GO_0002275) (myeloid cell activation involved in immune response), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0008138](http://purl.obolibrary.org/obo/GO_0008138) (protein tyrosine/serine/threonine phosphatase activity), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0043220](http://purl.obolibrary.org/obo/GO_0043220) (Schmidt-Lanterman incisure), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:2001159](http://purl.obolibrary.org/obo/GO_2001159) (regulation of protein localization by the Cvt pathway), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0021955](http://purl.obolibrary.org/obo/GO_0021955) (central nervous system neuron axonogenesis), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0051800](http://purl.obolibrary.org/obo/GO_0051800) (phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0032286](http://purl.obolibrary.org/obo/GO_0032286) (central nervous system myelin maintenance), [GO:0060074](http://purl.obolibrary.org/obo/GO_0060074) (synapse maturation), [GO:1990381](http://purl.obolibrary.org/obo/GO_1990381) (ubiquitin-specific protease binding), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0010941](http://purl.obolibrary.org/obo/GO_0010941) (regulation of cell death), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0090394](http://purl.obolibrary.org/obo/GO_0090394) (negative regulation of excitatory postsynaptic potential), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0097105](http://purl.obolibrary.org/obo/GO_0097105) (presynaptic membrane assembly), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0097107](http://purl.obolibrary.org/obo/GO_0097107) (postsynaptic density assembly), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0016479](http://purl.obolibrary.org/obo/GO_0016479) (negative regulation of transcription by RNA polymerase I), [GO:0061188](http://purl.obolibrary.org/obo/GO_0061188) (negative regulation of chromatin silencing at rDNA), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0031174](http://purl.obolibrary.org/obo/GO_0031174) (lifelong otolith mineralization), [GO:0031175](http://purl.obolibrary.org/obo/GO_0031175) (neuron projection development), [GO:0061186](http://purl.obolibrary.org/obo/GO_0061186) (negative regulation of chromatin silencing at silent mating-type cassette), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0070210](http://purl.obolibrary.org/obo/GO_0070210) (Rpd3L-Expanded complex), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0051717](http://purl.obolibrary.org/obo/GO_0051717) (inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:0060044](http://purl.obolibrary.org/obo/GO_0060044) (negative regulation of cardiac muscle cell proliferation), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0021513](http://purl.obolibrary.org/obo/GO_0021513) (spinal cord dorsal/ventral patterning), [GO:0045569](http://purl.obolibrary.org/obo/GO_0045569) (TRAIL binding), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0060291](http://purl.obolibrary.org/obo/GO_0060291) (long-term synaptic potentiation), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0060292](http://purl.obolibrary.org/obo/GO_0060292) (long term synaptic depression), [GO:0061002](http://purl.obolibrary.org/obo/GO_0061002) (negative regulation of dendritic spine morphogenesis), [GO:1903690](http://purl.obolibrary.org/obo/GO_1903690) (negative regulation of wound healing, spreading of epidermal cells), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:1904668](http://purl.obolibrary.org/obo/GO_1904668) (positive regulation of ubiquitin protein ligase activity), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:2000219](http://purl.obolibrary.org/obo/GO_2000219) (positive regulation of invasive growth in response to glucose limitation), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0010719](http://purl.obolibrary.org/obo/GO_0010719) (negative regulation of epithelial to mesenchymal transition), [GO:0031658](http://purl.obolibrary.org/obo/GO_0031658) (negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0060179](http://purl.obolibrary.org/obo/GO_0060179) (male mating behavior), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0033032](http://purl.obolibrary.org/obo/GO_0033032) (regulation of myeloid cell apoptotic process), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0008656](http://purl.obolibrary.org/obo/GO_0008656) (cysteine-type endopeptidase activator activity involved in apoptotic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:2000463](http://purl.obolibrary.org/obo/GO_2000463) (positive regulation of excitatory postsynaptic potential), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:0031642](http://purl.obolibrary.org/obo/GO_0031642) (negative regulation of myelination), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 56.86%
- [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia) 50.43%
- [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus) 50.43%
- [GO:0061408](http://purl.obolibrary.org/obo/GO_0061408) (positive regulation of transcription from RNA polymerase II promoter in response to heat stress) 50.43%
- [GO:0060746](http://purl.obolibrary.org/obo/GO_0060746) (parental behavior) 50.43%
- [GO:0051602](http://purl.obolibrary.org/obo/GO_0051602) (response to electrical stimulus) 50.43%
- [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm) 50.43%
- [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior) 50.43%
- [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior) 50.43%
- [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission) 50.43%
- [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia) 50.43%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process) 50.43%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:2000112](http://purl.obolibrary.org/obo/GO_2000112) (regulation of cellular macromolecule biosynthetic process) 50.43%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:1903508](http://purl.obolibrary.org/obo/GO_1903508) (positive regulation of nucleic acid-templated transcription) 50.43%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:1903506](http://purl.obolibrary.org/obo/GO_1903506) (regulation of nucleic acid-templated transcription) 50.43%


